Virax Biolabs Group Ltd Logo

Virax Biolabs Group Ltd

Biotechnology company specializing in immune response detection and viral disease diagnosis.

VRAX | US

Overview

Corporate Details

ISIN(s):
KYG9470A1094
LEI:
Country:
United States of America
Address:
BIOCITY GLASGOW, LANARKSHIRE

Description

Virax Biolabs Group Ltd. is an innovative biotechnology company specializing in the detection of immune responses and the diagnosis of viral diseases. The company's core activities center on T-cell diagnostics and comprehensive immune profiling, which provide critical insights into disease mechanisms and support the development of novel therapeutic strategies. Its primary technology is the ViraxImmune™ platform, a versatile In-Vitro Diagnostic (IVD) tool applicable across various conditions. Virax Biolabs also employs advanced research tools such as ELISpot assays, a highly sensitive and specific technique for monitoring T-cell activity. Through these offerings, the company aims to accelerate the development of more effective vaccines and contribute to global health.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Virax Biolabs Group Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Virax Biolabs Group Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Virax Biolabs Group Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

CAMBRIDGE COGNITION HOLDINGS PLC Logo
Develops digital solutions and a platform for CNS clinical trials to assess brain health.
United Kingdom
COG
A clinical-stage biopharmaceutical company developing novel cancer therapeutics.
Japan
4575
Captor Therapeutics S.A. Logo
Develops Targeted Protein Degradation therapies for cancer and autoimmune diseases.
Poland
CTX
Cardiff Oncology, Inc. Logo
A clinical-stage biotech developing cancer therapies that inhibit Polo-like kinase 1.
United States of America
CRDF
Cardio Diagnostics Holdings, Inc. Logo
Develops AI-powered epigenetic and genetic tests for early heart disease detection.
United States of America
CDIO
CASSAVA SCIENCES INC Logo
Clinical-stage biotech developing treatments for Central Nervous System disorders.
United States of America
SAVA
Celcuity Inc. Logo
Clinical-stage biotech developing targeted therapies for multiple solid tumors.
United States of America
CELC
Develops and manufactures cellulose-based nonwoven fabrics for the cosmetics sector.
South Korea
318160
CEL SCI CORP Logo
Clinical-stage biotech developing immunotherapies for cancer and infectious diseases.
United States of America
CVM
Celyad Oncology SA Logo
Biotechnology company developing innovative CAR-T cell therapies to treat cancer.
Belgium
CYAD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.